The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED).

Learn about the active and chronic phases of thyroid eye disease, symptoms, treatment options, surgical interventions, and ...

Thyroid eye disease (TED), also known as Graves’ eye disease or Graves’ ophthalmopathy, is an inflammatory condition in people with thyroid disease. Treatment may include medication, eye drops, and ...

Thyroid eye disease (TED) is an inflammatory condition affecting those with thyroid disease. There is no cure, but effective management strategies exist. Thyroid eye disease, or Graves’ ophthalmopathy ...

Reports of cases detail the development of thyroid eye disease 3-5 years following treatment of MS with immunomodulatory ...

Dry eye disease and migraine frequently occur together, and dry eyes can make migraine worse. Learn how treating dry eye disease can reduce the severity and frequency of your migraine attacks.

In the U.S., Hispanic/Latino populations are disproportionately at risk for eye diseases like glaucoma and diabetic ...

Viridian Therapeutics has fired a shot across Amgen's bows with FDA approval of Lumvoa, the first direct rival to Amgen's ...

Coats’ disease is an eye condition that can eventually lead to blindness. This rare disorder was first described by George Coats in 1908. It’s characterized by problems with the blood vessels in your ...

Dry eye disease is a condition that occurs when your eyes do not make enough tears or when your tears dry up too quickly. Tears are essential for keeping the surface of your eyes healthy, comfortable, ...